Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset

8 Apr 2021

Abstract excerpt

BACKGROUND: RNA vaccines against coronavirus disease 2019 (COVID-19) have demonstrated ∼95% efficacy in phase III clinical trials. Although complete vaccination consisted of 2 doses, the onset of protection for both licensed RNA vaccines was observed as early as 12 days after a single dose. The adaptive immune response that coincides with this onset of protection could represent the necessary elements of immunity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33851143
DOI: 10.1016/j.medj.2021.04.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 13 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onsetPMID 33851143Read ↗

Early T Cell and Binding Antibody Responses are Associated with COVID-19 RNA Vaccine Efficacy OnsetSemantic proximity Read ↗

Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine.Semantic proximity Read ↗

Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity Read ↗

Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adultsSemantic proximity Read ↗

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boostSemantic proximity Read ↗

Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSemantic proximity Read ↗

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case seriesSemantic proximity Read ↗

Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected personsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.